Stay updated on DARA/ATRA Combo in Myeloma: Clinical Trial

Sign up to get notified when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DARA/ATRA Combo in Myeloma: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record now presents details of the completed daratumumab and ATRA multiple myeloma study, including eligibility criteria, treatment plan, outcome measures, collaborators, and publication information.
    Difference
    51%
    Check dated 2026-11-09T13:16:16.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:54:50.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces that some content may use “Super Intelligence” instead of “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-26T16:34:00.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision number was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T16:39:59.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T16:46:12.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the site header and footer, indicating access to the study page is blocked.
    Difference
    0.5%
    Check dated 2026-09-28T20:17:48.000Z thumbnail image

Stay in the know with updates to DARA/ATRA Combo in Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.